undamentalytics Newsletter
Sign in

Morgan Stanley (MS) stock

Add to watchlist

Add holding +

NYSE: MS NYSE Investment Banking & Brokerage Next results ~January 14, 2027

B+ Fundamentals grade

Morgan Stanley is a US-listed company in the investment banking & brokerage industry. Its financial year ends in December.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Morgan Stanley files

Where Morgan Stanley stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $78.0bn, up 18.0% on a year earlier, faster than 14.2% a quarter earlier.

Our model value for Morgan Stanley is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 14, 2027 (estimated)

Morgan Stanley's trailing-twelve-month revenue grew 18.0% year on year, with a free-cash-flow margin of -25.6%. Where it stands out: change in share count of -1.4% ranks 6 of 35 investment banking & brokerage companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 12.2% while net income grew 36.6%: a 24pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 18.0% over the last 12 months, against a median of 20.8% for investment banking & brokerage companies we cover.
  • Growth speeding up. The growth rate is 3.8 points higher than a quarter earlier.
  • Shrinking share count. Diluted shares fell 1.4% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Burning cash. Free cash flow was -25.6% of revenue over the last 12 months.
  • High debt. Long-term debt exceeds cash by $223.0bn, more than 1.5 times annual revenue.
  • Insiders selling. 8 insiders sold $52M of stock over the past 365 days and none bought (0% under pre-set trading plans).
  • Weak cash conversion. Free cash flow was -99% of net income over the last 12 months.

Latest results: FY2026 Q2

Filed August 4, 2026
Earnings per share
$3.03 against an average estimate of $2.92: beat by 3.9%
Revenue
$21.35bn, up 27.1% on a year earlier
Share reaction
-2.4% in the first session after the results on October 14, 2026, against -0.8% for the S&P 500
Next report
January 14, 2027; average EPS estimate $2.98

Morgan Stanley's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.8%
  • 1 week+1.8%
  • 1 month-1.8%
  • This year+7.0%
  • 1 year+15.8%
  • 5 years+112.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$78B
Net margin
25.8%
EPS (TTM, diluted)
$12.76

Growth

Revenue growth
+18.0%
Change in growth rate
+3.8 pts
Share count change
−1.4%

Earnings

Last results
October 14, 2026
Next results (est.)
January 14, 2027

News & updates

Updated November 1, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Partnership
  2. Results
  3. Insider trade
  4. Insider trade
  5. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Morgan Stanley valuation models and calculator

No model value for Morgan Stanley at the moment. Current status: valuation models disagree too widely to rate. Available reported financials are shown below.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valuation models disagree too widely to rate: held for review.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Morgan Stanley as an asset manager, broker or exchange, with every model that fits that kind of business. Cost of equity 10.1%: the 10-year Treasury yield (4.9%) plus a beta of 1.13 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$200 ~$150–$310 Primary model, counts double
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$94 ~$71–$130 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$100 ~$88–$120 Included
Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. ~$7.3 ~$76–$330 Left out: out of range vs price (0.04x)
Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. ~$110 ~$91–$130 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Morgan Stanley with brokers, investment banks and exchanges in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

72 /100

Strong moat

How hard Morgan Stanley's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 11 / 20

    Net income has been a median 0.9% of total assets over 10 years.

  • Durability 17 / 20

    Net margin has been a median 21.3%; its worst year was 18.5%.

  • Discipline 19 / 20

    The diluted share count fell 10.0% over five years; stock-based pay has been a median 2.9% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (77 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: January 14, 2027, before the open. Analysts expect revenue of $20.3bn and EPS of $2.98 (range $2.80 to $3.22) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $12.85 +26% $82.3bn +17%
Next $13.61 +6% $86.5bn +5%

Next year's EPS estimate has moved −0.1% in 90 days, across 22 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −1.0% on 90 days ago. In the last 30 days, 1 analyst raised Morgan Stanley's forecast and 16 cut it.

Consensus EPS forecast Morgan Stanley, last 90 days
$12.50 $13.00 $13.50 $14.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $12.98 Current fiscal year, 60 days ago: $12.98 Current fiscal year, 30 days ago: $12.98 Current fiscal year, 7 days ago: $12.81 Current fiscal year, Now: $12.85 $12.85 Next fiscal year, 90 days ago: $13.63 Next fiscal year, 60 days ago: $13.65 Next fiscal year, 30 days ago: $13.68 Next fiscal year, 7 days ago: $13.66 Next fiscal year, Now: $13.61 $13.61

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $12.98$13.63
60 days ago $12.98$13.65
30 days ago $12.98$13.68
7 days ago $12.81$13.66
Now $12.85$13.61

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.92 $3.03 +3.9%
Jun 2026 $2.93 $3.46 +17.9%
Mar 2026 $3.02 $3.43 +13.7%
Dec 2025 $2.45 $2.68 +9.4%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 14, 2026

No numeric guidance in Morgan Stanley's latest earnings release (filed October 14, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

26 analysts, Oct 2026
Buy1142%
Hold1454%
Sell14%

Monthly trend

  1. Oct 2026291426
  2. Sep 2026291325
  3. Aug 2026291225
  4. Jul 2026291325

Counts of recommendations published by analysts covering Morgan Stanley, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
0.0%
of tradable shares
Days to cover
0
at average volume
Short interest, 1 month
−100%
to October 15, 2026
Held by institutions
63%
of shares
Held by insiders
24.4%
of shares
Employees
83,728
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +15.8%

$160.36 on October 31, 2025 to $185.73

ThenNowEffect
Revenue (last 12 months) $66.1bn $78.0bn +18.0%
Net margin 22.3% 25.8% +15.8%
P/E multiple 17.4x 14.6x −16.4%
Share count 1603m 1580m +1.4%

Biggest factor: p/e multiple.

Last 3 years +165.4%

$69.99 on November 3, 2023 to $185.73

ThenNowEffect
Revenue (last 12 months) $53.7bn $78.0bn +45.3%
Net margin 18.7% 25.8% +38.3%
P/E multiple 11.7x 14.6x +24.8%
Share count 1672m 1580m +5.8%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
MS+47%−10%+14%+40%+45%+7%
Industry peers (median)+26%−20%+19%+45%+8%−16%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
MS75%50%50%58%75%64%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
MS−12%−32%−29%−13%−29%−22%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 51% from January 17, 2020 to March 23, 2020. Getting back needed a 105% gain, reached on November 9, 2020, 231 days after the low.

Price behaviour

52-week range
$151.78 – $225.92
From 52-week high
−17.8%
vs 50-day average
−5.4%
vs 200-day average
−3.3%
Volatility (1 year)
28%
Beta vs S&P 500
1.44

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 2 down
typical move ±3.3%
After a week
2 up, 2 down
typical move ±2.4%
After a month
1 up, 2 down
typical move ±5.0%
Results releasedNext dayS&P 500 next day5 days21 days
October 14, 2026 −2.4% −0.8% +0.2% —
July 15, 2026 −4.1% −0.1% −4.0% −3.6%
April 15, 2026 +2.2% +1.0% +4.2% +6.7%
January 15, 2026 +4.6% +0.2% −1.0% −4.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Morgan Stanley in five measures

Fundamentals grade B+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Morgan Stanley
$50B $60B $70B $80B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $54B Revenue (TTM), FY23 Q4: $54.1B Revenue (TTM), FY24 Q1: $54.8B Revenue (TTM), FY24 Q2: $56.3B Revenue (TTM), FY24 Q3: $58.4B Revenue (TTM), FY24 Q4: $61.8B Revenue (TTM), FY25 Q1: $64.4B Revenue (TTM), FY25 Q2: $66.1B Revenue (TTM), FY25 Q3: $69B Revenue (TTM), FY25 Q4: $70.6B Revenue (TTM), FY26 Q1: $73.5B Revenue (TTM), FY26 Q2: $78B $78B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $54B
FY23 Q4 $54.1B
FY24 Q1 $54.8B
FY24 Q2 $56.3B
FY24 Q3 $58.4B
FY24 Q4 $61.8B
FY25 Q1 $64.4B
FY25 Q2 $66.1B
FY25 Q3 $69B
FY25 Q4 $70.6B
FY26 Q1 $73.5B
FY26 Q2 $78B
Revenue growth, TTM YoY Morgan Stanley
-10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -2.6% Revenue growth, TTM YoY, FY23 Q4: 0.9% Revenue growth, TTM YoY, FY24 Q1: 2.6% Revenue growth, TTM YoY, FY24 Q2: 4.9% Revenue growth, TTM YoY, FY24 Q3: 8.2% Revenue growth, TTM YoY, FY24 Q4: 14.1% Revenue growth, TTM YoY, FY25 Q1: 17.5% Revenue growth, TTM YoY, FY25 Q2: 17.4% Revenue growth, TTM YoY, FY25 Q3: 18.0% Revenue growth, TTM YoY, FY25 Q4: 14.4% Revenue growth, TTM YoY, FY26 Q1: 14.2% Revenue growth, TTM YoY, FY26 Q2: 18.0% 18.0%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -2.6%
FY23 Q4 0.9%
FY24 Q1 2.6%
FY24 Q2 4.9%
FY24 Q3 8.2%
FY24 Q4 14.1%
FY25 Q1 17.5%
FY25 Q2 17.4%
FY25 Q3 18.0%
FY25 Q4 14.4%
FY26 Q1 14.2%
FY26 Q2 18.0%
FCF margin (TTM) Morgan Stanley
-80% -60% -40% -20% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -62.7% FCF margin (TTM), FY23 Q4: -69.8% FCF margin (TTM), FY24 Q1: -43.1% FCF margin (TTM), FY24 Q2: -20.9% FCF margin (TTM), FY24 Q3: -56.7% FCF margin (TTM), FY24 Q4: -6.2% FCF margin (TTM), FY25 Q1: -49.8% FCF margin (TTM), FY25 Q2: -34.4% FCF margin (TTM), FY25 Q3: -12.8% FCF margin (TTM), FY25 Q4: -31.9% FCF margin (TTM), FY26 Q1: -7.5% FCF margin (TTM), FY26 Q2: -25.6% -25.6%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -62.7%
FY23 Q4 -69.8%
FY24 Q1 -43.1%
FY24 Q2 -20.9%
FY24 Q3 -56.7%
FY24 Q4 -6.2%
FY25 Q1 -49.8%
FY25 Q2 -34.4%
FY25 Q3 -12.8%
FY25 Q4 -31.9%
FY26 Q1 -7.5%
FY26 Q2 -25.6%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

What Morgan Stanley earned on its loans and securities in FY2025, what it paid depositors and lenders, and how its revenue split between running costs, credit losses, tax and profit.

  1. Interest income $59.1B
  2. Fee and other income $60.6B · 85.8%
  3. Interest paid $49B
  4. Net interest income $10B · 14.2%
  5. Revenue $70.6B
  6. Non-interest expense $48.3B · 68.4%
  7. Pre-tax profit $22.1B · 31.2%
  8. Income tax $4.9B · 7.0%
  9. Net income $16.9B · 23.9%

Shares of revenue. Source: Morgan Stanley's 10-K for FY2025, as filed with the SEC.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 23.3 31.2 32.2 26.2 32.5 34.3 35.2 34.6 37.9 40.1 41.5 48.8 59.8 53.7 54.1 61.8 70.6 78.0
Net income 1.3 4.7 4.1 0.1 2.9 3.5 6.1 6.0 6.1 8.7 9.0 11.0 15.0 11.0 9.1 13.4 16.9 20.2
Diluted EPS −$0.77 $2.63 $1.23 −$0.02 $1.36 $1.60 $2.90 $2.92 $3.07 $4.73 $5.19 $6.46 $8.03 $6.15 $5.18 $7.95 $10.21 $12.76
Growth (year on year)
Revenue +5.1% +34.1% +3.2% −18.8% +24.1% +5.5% +2.6% −1.5% +9.6% +5.7% +3.6% +17.4% +22.6% −10.2% +0.9% +14.1% +14.4% +18.0%
Net income −21.1% +249.4% −12.6% −98.3% — +18.2% +76.7% −2.4% +2.2% +43.2% +3.4% +21.6% +36.7% −26.6% −17.6% +47.4% +25.9% +36.6%
Diluted EPS −155.4% — −53.2% −101.6% — +17.6% +81.3% +0.7% +5.1% +54.1% +9.7% +24.5% +24.3% −23.4% −15.8% +53.5% +28.4% +38.5%
Margins
Net margin 5.8% 15.1% 12.8% 0.3% 9.0% 10.1% 17.4% 17.3% 16.1% 21.8% 21.8% 22.6% 25.2% 20.6% 16.8% 21.7% 23.9% 25.8%
Cash flow
Cash from operations −46.0 40.6 15.9 24.5 35.0 1.1 −4.5 5.4 −4.5 7.3 40.8 −25.2 34.0 −6.4 −33.5 1.4 −17.9 −15.6
Stock-based pay 1.3 1.3 1.3 0.9 1.2 1.3 1.1 1.1 1.0 0.9 1.2 1.3 2.1 1.9 1.7 1.6 1.9 2.1
Balance sheet
Cash 32.0 47.6 47.3 46.9 59.9 87.6 85.6 77.4 80.4 87.2 82.2 105.7 127.7 128.1 89.2 105.4 111.7 160.1
Total debt 195.8 195.7 187.1 171.7 155.7 155.0 155.9 165.7 192.6 189.7 192.6 217.1 233.1 238.1 263.7 288.8 348.9 392.6
Net debt (negative = net cash) 163.8 148.1 139.8 124.8 95.8 67.4 70.4 88.4 112.2 102.5 110.5 111.4 105.4 109.9 174.5 183.4 237.2 232.4
Diluted shares 1,185m 1,411m 1,675m 1,919m 1,957m 1,971m 1,953m 1,887m 1,821m 1,738m 1,640m 1,624m 1,814m 1,713m 1,646m 1,611m 1,592m 1,580m
Returned to shareholders
Dividends 1.7 1.2 0.8 0.5 0.5 0.9 1.5 1.7 2.1 2.4 2.6 2.7 4.2 5.4 5.8 6.1 6.6 6.8
Buybacks 0.1 0.3 0.3 0.2 0.7 — — — — — — — — — — — — —
Total returned 1.8 1.5 1.2 0.7 1.2 0.9 1.5 1.7 2.1 2.4 2.6 2.7 4.2 5.4 5.8 6.1 6.6 6.8

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

Dividends (TTM)
$6.8B
Diluted share count
−1.4%
year over year
Total shareholder yield
2.3%
dividends 2.3% + buybacks 0.0% of market value
Dividend payout ratio
34%
of net income paid out

Competitors: side by side with peers

Closest by revenue in investment banking & brokerage
Last 12 months unless stated MS GS SNEX SCHW LPLA RJF Median
Revenue, last 12 months $78.0bn $69.7bn $157.7bn $26.0bn $20.4bn $17.0bn $2.0bn
Revenue growth, last 12 months 18.0% 18.7% 20.6% 20.3% 31.0% 8.0% 20.7%
Revenue growth, 3-year average 13.3% 15.3% 37.5% 7.8% 27.9% 10.8% 16.2%
Revenue growth, latest quarter 27.1% 23.0% 15.4% 20.9% 17.4% 13.5% 17.4%
Net margin 25.8% 31.8% 0.3% 38.8% 6.8% 13.6% 5.8%
Cash from operations / revenue −20.0% −54.3% 2.4% 43.9% 8.7% 9.6% 7.7%
Free-cash-flow margin −25.6% −57.4% 2.4% 41.5% 4.9% 8.5% 5.2%
Free-cash-flow margin, 3-year average −27.0% −69.3% 1.3% 56.3% −2.2% 11.3% 16.8%
Stock pay / revenue 2.6% 5.0% 0.0% 1.3% 0.4% 1.4% 4.7%
Change in share count −1.4% −4.6% 1.7% −3.2% 2.8% −3.9% 1.2%

Median of all 40 companies we cover in investment banking & brokerage. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

40 investment banking & brokerage companies
Measure Company Peer median Rank
Revenue growth Growth 18.0% 20.8% 24 of 40
Change in growth rate Growth +3.8pp -0.3pp 12 of 40
Net margin Profitability 25.8% 6.0% 8 of 40
Stock pay as % of revenue Cash generation 2.6% 4.8% 14 of 36
Change in share count Balance sheet -1.4% 1.2% 6 of 35

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$282B
Institutions reporting
2,724
Shares held vs prior quarter
▲ 1.6%
Positions opened / closed
320 / 89

Top buyers and sellers, Q2 2026: 1,417 institutions bought and 1,023 sold ; the biggest buyer was Capital World Investors (+8.6M shares) and the biggest seller Millennium Management LLC (−3.5M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Mitsubishi Ufj Financial Group Inc $78.8B 377.1M 28.0% 0.0%
State Street Corp $20.8B 99.6M 7.4% ▼ 1.8%
Blackrock, Inc. $19.8B 94.9M 7.0% ▼ 1.6%
Vanguard Capital Management LLC $16.2B 77.7M 5.8% 0.0%
Jpmorgan Chase & Co $9.4B 44.4M 3.3% ▲ 1.8%
Vanguard Portfolio Management LLC $6.3B 30.2M 2.2% ▼ 0.1%
Geode Capital Management, LLC $5.7B 27.3M 2.0% ▼ 1.3%
Fisher Asset Management, LLC $5.5B 26.2M 1.9% ▲ 2.2%
FMR LLC $5.2B 24.9M 1.8% ▲ 9.6%
Price T Rowe Associates Inc $4B 19.2M 1.4% ▲ 13.1%
Capital Research Global Investors $3.8B 18.1M 1.3% ▼ 10.9%
Norges Bank $3.8B 18.0M 1.3% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Morgan Stanley's complete shareholder register. Values are as reported by the filers ; 12 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $51.7M 33 trades by 8 insiders · 0% under pre-set plans
Net ▼ $51.7M net selling
Insider Date Trade Shares Price Value
Schapiro Mary L Director July 28, 2026 Sell 1,000 $212.06 $212,055
Pizzi Michael A. Head Technology & Operations July 17, 2026 Sell 7,101 $216.88 $1.5M
Pizzi Michael A. Head Technology & Operations July 17, 2026 Sell 17,064 $215.00 $3.7M
Yeshaya Sharon Chief Financial Officer July 16, 2026 Sell 9,172 $222.51 $2M
Yeshaya Sharon Chief Financial Officer July 16, 2026 Sell 6,382 $222.51 $1.4M
Grossman Eric F Chief Legal/Admin Officer April 20, 2026 Sell 5,559 $191.50 $1.1M
Grossman Eric F Chief Legal/Admin Officer April 20, 2026 Sell 5,559 $190.00 $1.1M
Simkowitz Daniel A Co-President April 17, 2026 Sell 14,690 $189.24 $2.8M
Crawley Mandell Chief Client Officer April 16, 2026 Sell 300 $189.05 $56,714
Crawley Mandell Chief Client Officer April 16, 2026 Sell 13,283 $188.38 $2.5M
Crawley Mandell Chief Client Officer April 16, 2026 Sell 2,546 $187.25 $476,743
Saperstein Andrew M Co-President April 16, 2026 Sell 600 $192.12 $115,269

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 72 trades and filings

In the last 12 months, 4 members of Congress disclosed 2 purchases and 3 sales of Morgan Stanley shares.

  • Dan Newhouse(R-WA 4):Purchase, $1,001 - $15,000, traded July 10, 2026, filed July 17, 2026
  • Julie Johnson(D-TX 32):Sale (full), $1,001 - $15,000, traded December 18, 2025, filed January 15, 2026
  • Steve Cohen(D-TN 9):Sale (partial), $50,001 - $100,000, traded December 17, 2025, filed January 14, 2026

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 14, 2027 estimated from the company's past filing pattern, not announced

  • October 14, 2026
  • July 15, 2026
  • April 15, 2026
  • January 15, 2026

Recent SEC filings

Data status

When each part of this page on Morgan Stanley was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Morgan Stanley in brief

What does Morgan Stanley do?
Morgan Stanley is a US-listed company in the investment banking & brokerage industry. Its financial year ends in December.
What is Morgan Stanley's stock ticker?
Morgan Stanley trades under the ticker MS on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Morgan Stanley's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Morgan Stanley reported revenue of $78B, 18.0% higher than a year earlier, according to its SEC filings.
What is Morgan Stanley's free cash flow?
Morgan Stanley's free-cash-flow margin is -25.6% of revenue over the trailing twelve months.
Who are Morgan Stanley's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Mitsubishi Ufj Financial Group Inc, State Street Corp and Blackrock, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Morgan Stanley's market cap?
On November 2, 2026, Morgan Stanley's market capitalisation was about $293B, with a price-to-earnings ratio of 14.6 and net debt of $232B. Market figures come from third-party market data and may be delayed.
Does Morgan Stanley pay a dividend?
Yes: Morgan Stanley paid $6.8B in dividends over the trailing twelve months, a dividend yield of 2.32% and a payout ratio of 33.6%.
Who are Morgan Stanley's competitors?
In our Investment Banking & Brokerage peer group, the companies closest to Morgan Stanley are Goldman Sachs, Stonex Group Inc., Charles Schwab Corporation, LPL Financial Holdings Inc. and Raymond James Financial. The side-by-side comparison below sets their revenue, margins and growth against Morgan Stanley's.
Are insiders buying or selling Morgan Stanley stock?
Over the last 12 months, Morgan Stanley's directors and officers reported 0 open-market purchases and 33 sales on Form 4. The insider trading page charts every trade.
When is Morgan Stanley's next earnings date?
Around January 14, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Morgan Stanley announces its own schedule.